Zycoxia MR 60mg/4mg Tablet is a combination medication containing Etoricoxib 60mg and Thiocolchicoside 4mg, formulated for the management of musculoskeletal pain and inflammation. Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, provides effective anti-inflammatory and analgesic effects by reducing the synthesis of prostaglandins involved in pain and inflammation pathways, thereby minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs. Thiocolchicoside is a muscle relaxant with anti-inflammatory properties that acts by modulating glycine receptors and inhibiting excitatory neurotransmission, resulting in relief from muscle spasms and stiffness. The combination of these agents in Zycoxia MR offers dual therapeutic benefits, addressing both inflammatory pain and muscle spasm simultaneously. This makes it particularly useful in conditions such as osteoarthritis, rheumatoid arthritis, low back pain, and other musculoskeletal disorders where inflammation and muscle spasm coexist. The modified-release formulation ensures sustained plasma concentrations, enhancing patient compliance and providing prolonged symptom relief. Zycoxia MR should be used under medical supervision, with caution advised in patients with cardiovascular risk factors, hepatic or renal impairment, and a history of gastrointestinal disorders. It is contraindicated in individuals with hypersensitivity to its components.